Cures Act

FDA Partners with COTA Inc. to Embrace Real-World Evidence for Breast Cancer Insights

Jul 10, 2019 | Breast Cancer, Cures Act, FDA, Oncology, Real-world data, Real-World Evidence, RWD, RWE

COTA, Inc. positions itself as a leading precision medicine technology company utilizing real-world evidence to bring clarity to cancer care, recently announced it has signed a two-year Research Collaboration Agreement (RCA) with the U.S. Food and Drug Administration...

FDA Partners with COTA Inc. to Embrace Real-World Evidence for Breast Cancer Insights

Popular Links

Connect With Us

Pin It on Pinterest